IP Library › Granted Patent US 7,632,232
Granted Patent B2
US 7,632,232 · App. 10/729,199 · Granted Dec 15, 2009

Ultrasonic detection of ear disorders

Assignee: Otosonics Inc.
View Patent ↗
Loading inventors, assignments & file history…
Monitor This Case
Get email alerts when status or documents change.
Order Certified Copies
Most orders are placed with the USPTO same day — all within 24 business hours.
Order via The Patent Place →
Pre-filled with this patent's details
Quick Facts
Patent No.
US 7,632,232
App. No.
10/729,199
Granted
Dec 15, 2009
Kind
B2
Abstract

An apparatus and method for determining ear fluid viscosity. A transducer is operable to transceive a signal to interact with a fluid-containing portion of the ear. The viscosity of the fluid is determined using the transcieved signal.

Claims (18)

1. A method for testing for otitis media, comprising the steps of:

positioning an ultrasound probe at a location spaced away from a tympanic membrane of a human patient;

using the ultrasound probe to detect the presence and measure the viscosity of a middle ear effusion in the human patient while the ultrasound probe is positioned at the location spaced away from the tympanic membrane, wherein the viscosity of the middle ear effusion is measured based on an analysis of a first pulse echo reflected from the tympanic membrane and a second pulse echo reflected from a middle ear cavity of the human patient; and comparing the measured viscosity of the middle ear effusion in the human patient with at least three predetermined values for effusion viscosity, wherein such comparison provides information regarding the likelihood of presence of bacterial infection in the middle ear effusion in the human patient.

2. The method for testing of claim 1 wherein each of said predetermined values is based on a plurality of predetermined ranges of fluid viscosity measurements.

3. The method of claim 1 , wherein the ultrasonic probe contains a plurality of transducers that are each adapted to transceive an ultrasonic signal.

4. A method for determining if a human patient is a candidate for receiving antibiotic treatment, wherein the presence of a middle ear effusion in the patient is detected by an ultrasound probe that is positioned at a location spaced away from a tympanic membrane of the human patient and the viscosity of the middle ear effusion is determined based on an analysis of a first pulse echo reflected from the tympanic membrane and a second pulse echo reflected from a middle ear cavity of the human patient, and comparing the determined viscosity of the middle ear effusion with at least one predetermined fluid viscosity value.

5. The method of claim 4 , wherein the ultrasonic probe contains a plurality of transducers that are each adapted to transceive an ultrasonic signal.

6. An apparatus for determining the viscosity of a fluid in a middle ear cavity, the apparatus including:

a plurality of transducers that are each adapted to transceive an ultrasonic signal to interact with a tympanic membrane and the middle ear cavity,

wherein the apparatus is configured to use pulse echo amplitudes to determine whether the fluid in the middle ear cavity is serous, purulent or mucoid while the plurality of transducers are positioned at a location spaced away from the tympanic membrane, wherein the apparatus is configured to determine the viscosity of the fluid in the middle ear cavity by an analysis of pulse echo amplitudes, measured by at least one of the plurality of transducers, of a first pulse echo reflected from the tympanic membrane and a second pulse echo reflected from the middle ear cavity.

7. The apparatus of claim 6 , wherein the plurality of transducers are arranged in a curved array.

8. A method of determining the viscosity of a fluid in a middle ear cavity, the method including:

positioning a plurality of transducers at a location spaced away from a tympanic membrane;

operating a plurality of transducers while the plurality of transducers are positioned at the location spaced away from the tympanic membrane, wherein the viscosity of the fluid in the middle ear cavity is measured based on an analysis of a first pulse echo reflected from the tympanic membrane and a second pulse echo reflected from the middle ear cavity; and

using amplitudes from the first pulse echo and the second pulse echo to determine whether the fluid in the middle ear cavity is serous, purulent or mucoid.

9. The method of claim 8 , wherein the plurality of transducers are operated sequentially.

10. The method of claim 8 , wherein the plurality of transducers are operated simultaneously.

11. The method of claim 8 , wherein the plurality of transducers is are each adapted to transceive an ultrasonic signal.

Assignments (5)
ASSIGNMENT OF ASSIGNOR'S INTEREST Recorded Aug 10, 2009
From: ELECTRONSONICS MEDICAL INC.
To: OTOSONICS INC.
Reel/Frame 023065/0894 →
CONFIRMATORY LICENSE Recorded Jul 9, 2008
From: BIOMEC INC.
To: NATIONAL INSTITUTES OF HEALTH (NIH), U.S. DEPT. OF HEALTH AND HUMAN SERVICES (DHHS), U.S. GOVERNMENT
Reel/Frame 021209/0900 →
CHANGE OF NAME Recorded May 18, 2007
From: BIOMEC INC.
To: ELECTROSONICS MEDICAL INC.
Reel/Frame 019304/0752 →
ASSIGNMENT OF ASSIGNOR'S INTEREST Recorded Apr 11, 2006
From: LEWANDOWSKI, JAN; BESSLER, ROBERT A.
To: BIOMEC, INC.
Reel/Frame 017772/0487 →
ASSIGNMENT OF ASSIGNOR'S INTEREST Recorded May 17, 2004
From: LEWANDOWSKI, JAN
To: BIOMEC, INC.
Reel/Frame 015331/0735 →
Continuity (3)
Provisional Application 6044286900 · Jan 27, 2003
Provisional Application 6043219100 · Dec 6, 2002
Related Publication 20040138561A1 · Jul 15, 2004